Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 36 of 36 entries
View as:

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime

Phase: N/A Priority: Normal
NCT ID: NCT02532140 Org: User:
Start: 08/31/15 End: 12/31/15 Due: 12/31/16

Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03979859 Org: User:
Start: 08/20/13 End: 12/30/13 Due: 12/30/14

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01400789 Org: User:
Start: - End: - Due: -

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02674347 Org: User:
Start: 02/29/16 End: 04/30/16 Due: 04/30/17

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01400802 Org: User:
Start: 11/30/11 End: 06/30/12 Due: 06/30/13

Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01358435 Org: User:
Start: 01/31/11 End: 05/31/11 Due: 05/31/12

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin

Phase: N/A Priority: Normal
NCT ID: NCT03981887 Org: User:
Start: 06/18/19 End: 08/07/19 Due: 08/07/20

To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02942810 Org: User:
Start: 10/25/16 End: 04/30/17 Due: 04/30/18

Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Phase: N/A Priority: Normal
NCT ID: NCT04979806 Org: User:
Start: 08/28/22 End: 01/04/25 Due: 01/04/26

Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Phase: N/A Priority: Normal
NCT ID: NCT03405064 Org: User:
Start: 08/25/17 End: 11/30/18 Due: 11/30/19

Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02253342 Org: User:
Start: 09/30/14 End: 08/31/15 Due: 08/31/16